C75 FIBROSIS: CURRENT AND FUTURE APPROACHES: Preclinical Studies Reveal Low Phosphate Diet As A Potential Therapy For Pulmonary Alveolar Microlithiasis

Serum biomarkers that were measured serially included surfactant protein-D (SP-D) as a marker of barrier integrity, and monocyte chemotactic protein-1 (MCP-1), as a marker of lung inflammation. Serum levels of key mediators of phosphate metabolism were measured including fibroblast growth factor 23...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Uehara, Y, Nikolaidis, N M, Saito, A, Pitstick, L B, Wu, H, Amlal, H, LaSance, K, Woods, J C, Guo, J, McCormack, F X
Format: Article
Language:English
Subjects:
Diet
Inflammation
Rodents
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Serum biomarkers that were measured serially included surfactant protein-D (SP-D) as a marker of barrier integrity, and monocyte chemotactic protein-1 (MCP-1), as a marker of lung inflammation. Serum levels of key mediators of phosphate metabolism were measured including fibroblast growth factor 23 (FGF-23), parathyroid hormone (PTH) and 1,25-dihydroxy vitamin D (1,25(OH)Vit D).
ISSN:1073-449X
1535-4970